EZZ 1.84% $1.94 ezz life science holdings limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5

  1. 4,248 Posts.
    lightbulb Created with Sketch. 449
    Good to see that there is no particular one off to explain this good level of free cash flow (just a confirmation that they had a free cash flow of around 5 m$ during the quarter).

    Overall, I find this quarter really positive :
    - confirmation of strong growth for their receipts (+ 70 % yoy after + 111 % yoy in Q3*),
    - clear operating leverage, looking at ad and marketing (50.9 % of receipts vs 57.6 % in Q3) and product manufacturing and operating costs (21.7 % of receipts vs 26.7 % in Q3).

    So, if we annualise this quarter, the company has a free cash flow yield of 21.4 %, while it is growing its receipts by 70 %.
    I'd like to find other companies with such a profile.
    Main risk in the short term remains their high exposure to China.

    * boosted by delayed payment, so Q4 is probably a better reflection of the normalised growth of the company.
    Last edited by saintex: 23/07/24
 
watchlist Created with Sketch. Add EZZ (ASX) to my watchlist
(20min delay)
Last
$1.94
Change
0.035(1.84%)
Mkt cap ! $85.93M
Open High Low Value Volume
$1.96 $1.98 $1.91 $107.8K 55.41K

Buyers (Bids)

No. Vol. Price($)
2 2982 $1.91
 

Sellers (Offers)

Price($) Vol. No.
$1.96 1923 1
View Market Depth
Last trade - 15.59pm 23/08/2024 (20 minute delay) ?
EZZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.